Rheumatology Review spend and funding (FOI)Rheumatology Review spend and funding (FOI)
Produced by the Freedom of Information officeAuthored by Government of Jersey and published on
21 June 2024.Prepared internally, no external costs.
Request
In the Health and Community Services (HCS) Advisory Board pack it was explained that HCS had submitted a business case to Treasury for 2024 seeking further funding to deal with the repercussions of the rheumatology review.
Please confirm how much is being asked for and whether this has been approved yet.
The Board pack also referenced the fact that HCS received £1.3million from Treasury during 2023 to support the work required in the rheumatology department, and said that this money was largely spent on the use of specialist consultants to review the circa 2,500 patients under rheumatology service.
Please provide a breakdown of how the £1.3m was spent?
Response
Expenditure against the 2023 funds allocated is detailed in the table below. All figures have been rounded to whole pounds.
Cost Type | Spend (£) |
| Education and Training | 3,002 |
| Electronic Component | 8,332 |
| Financial and Insurance Services | 2,240 |
| Healthcare Agency | 866,981 |
| Healthcare Services | 29,850 |
| Information Technology and Telecommunications | 1,698 |
| Medical Equipment and Supplies | 57,364 |
| Medical Practice | 82,026 |
| Management Consultancy | 158 |
| Office Equipment and Supplies | 57,364 |
| Passenger Transport | 497 |
| Purchase of Care | 5,285 |
| Security and Courts | 527 |
| Staff Costs | 234,021 |
| Technology Services | 360 |
| Transportation Services | 121 |
| Total | 1,302,354 |
Funding of £1,170,398 has been allocated for 2024.
gov.je